SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-008484
Filing Date
2023-06-27
Accepted
2023-06-27 16:45:34
Documents
17
Period of Report
2023-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm   iXBRL 8-K 33717
2 EMPLOYMENT AGREEMENT edsa_ex101.htm EX-10.1 56362
3 PRESS RELEASE edsa_ex991.htm EX-99.1 11524
9 edsa_ex101img5.jpg GRAPHIC 3073
  Complete submission text file 0001654954-23-008484.txt   245050

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA edsa-20230626.xsd EX-101.SCH 5720
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20230626_lab.xml EX-101.LAB 13488
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20230626_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20230626_pre.xml EX-101.PRE 8503
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20230626_def.xml EX-101.DEF 2099
11 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3309
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 231047962
SIC: 2834 Pharmaceutical Preparations